1
Benjamin Oshlack, Mark Chasin, Frank Pedi Jr: Controlled release formulations coated with aqueous dispersions of acrylic polymers. Euro Celtique, Steinberg Raskin & Davidson P C, June 17, 1997: US05639476 (535 worldwide citation)

A stable solid controlled release formulation having a coating derived from an aqueous dispersion of a hydrophobic acrylic polymer includes a substrate including an active agent selected from the group consisting of a systemically active therapeutic agent, a locally active therapeutic agent, a disin ...


2
Benjamin Oshlack, Mark Chasin, John J Minogue, Robert F Kaiko: Controlled release oxycodone compositions. Euro Celtigue, Steinberg Raskin & Davidson, April 16, 1996: US05508042 (251 worldwide citation)

A method for substantially reducing the range in daily dosages required to control pain in approximately 90% of patients is disclosed whereby an oral solid controlled release dosage formulation having from about 10 to about 40 mg of oxycodone or a salt thereof is administered to a patient. The formu ...


3
Benjamin Oshlack, Mark Chasin, Frank Pedi Jr: Controlled-release formulations coated with aqueous dispersions of ethylcellulose. Euroceltique, Steinberg Raskin & Davidson, December 5, 1995: US05472712 (235 worldwide citation)

A stabilized solid controlled release formulation having a coating derived from an aqueous dispersion of a hydrophobic polymer is obtained by overcoating a substrate including an active agent selected from the group consisting of a systemically active therapeutic agent, a locally active therapeutic ...


4
Benjamin Oshlack, Mark Chasin, John J Minogue, Robert F Kaiko: Controlled release oxycodone compositions. Euro Celtique, Steinberg Raskin & Davidson P C, August 27, 1996: US05549912 (232 worldwide citation)

A method for substantially reducing the range in daily dosages required to control pain in approximately 90% of patients is disclosed whereby an oral solid controlled release dosage formulation having from about 10 to about 40 mg of oxycodone or a salt thereof is administered to a patient. The formu ...


5
Richard Sackler, Paul Goldenheim, Robert Kaiko: Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level. Euroceltique, Steinberg Raskin & Davidson, December 26, 1995: US05478577 (224 worldwide citation)

Patients are treated with 24-hour oral sustained release opioid formulations which upon administration quickly release an effective portion of the opioid contained therein such that there is an initially more rapid opioid release so that the minimum effective analgesic concentration of the opioid ca ...


6
Benjamin Oshlack, James McGinity, Mark Chasin, Roland Bodmeier: Controlled release coatings derived from aqueous dispersions of zein. Euroceltique, Steinberg Raskin & Davidson, October 18, 1994: US05356467 (219 worldwide citation)

Stable aqueous dispersions of zein which may be used as controlled release coatings of pharmaceutical, animal, health, or food products in an inorganic solvent-free environment are disclosed, as well as methods for preparing the same.


7
Benjamin Oshlack, Mark Chasin, John Joseph Minogue, Robert Francis Kaiko: Controlled release oxycodone compositions. Euro Celtique, Steinberg Raskin & Davidson P C, August 12, 1997: US05656295 (218 worldwide citation)

A method for substantially reducing the range in daily dosages required to control pain in approximately 90% of patients is disclosed whereby an oral solid controlled release dosage formulation having from about 10 to about 40 mg of oxycodone or a salt thereof is administered to a patient. The formu ...


8
Richard S Sackler, Robert F Kaiko, Paul Goldenheim: Method of treating pain by administering 24 hour oral opioid formulations. Purdue Pharma, Steinberg Raskin & Davidson P C, September 30, 1997: US05672360 (214 worldwide citation)

Patients are treated with 24-hour oral sustained release opioid formulations which, upon administration, provide an initially rapid opioid absorption such that the minimum effective analgesic concentration of the opioid is more quickly achieved. These sustained release opioid formulations include an ...


9
Benjamin Oshlack, Frank Pedi Jr, Mark Chasin: Controlled release formulations coated with aqueous dispersions of acrylic polymers. Euro Celtique, Steinberg Raskin & Davidson P C, December 3, 1996: US05580578 (193 worldwide citation)

A stable solid controlled release formulation having a coating derived from an aqueous dispersion of a hydrophobic acrylic polymer includes a substrate including an active agent selected from the group consisting of a systemically active therapeutic agent, a locally active therapeutic agent, a disin ...


10
Benjamin Oshlack, Mark Chasin: Immediate release tablet cores of insoluble drugs having sustained-release coating. Euro Celtique, Steinberg Raskin & Davidson, March 19, 1996: US05500227 (172 worldwide citation)

A controlled release tablet for oral administration is disclosed which has a tablet core including an insoluble therapeutically active agent having an aqueous solubility of less than or equal to about 5 mg/ml in a sufficient amount to render a therapeutic effect. The core provides rapid release of s ...



Click the thumbnails below to visualize the patent trend.